Highlights from the Week of 19th October – 26th October in the world of pharma and healthcare!

Highlights from the Week of 19th October 2026 - 26th October 2026 ( FDA , Approval ) FDA approves GSK's JEMPERLI for adults with stage II and III MSI-H or dMMR locally advanced rectal cancer ( FDA , Approval ) GSK's HIBSAGO receives FDA approval for the treatment of CHB in combination with Nrtl therapy in adults without cirrhosis ( FDA , Approval ) FDA gives approval to AbbVie's SKYRIZI SC induction regimen for adults with moderately to severely active CD ( EC, Approval ) Novartis receives EC approval for COSENTYX indicated to treat adults with PMR with inadequate response to glucocorticoids or relapse during taper Pg 1/4 All logos and trademarks remain the intellectual properties of their respective owners

Connect with us

Please fill in the information below, and we'll get back to you.